DHR Danaher
- 248.760
- +1.360+0.55%
- 248.750
- -0.0100.00%
Danaher News
Raymond James Adjusts Price Target on Danaher to $285 From $270, Keeps Outperform Rating
TD Cowen: Maintains Danaher (DHR.US) rating, adjusted from buy to buy rating, and adjusted target price from $280.00 to $290.00.
B of A Securities: Maintaining the Danaher (DHR.US) rating, adjusted from neutral to neutral, and adjusted the target price from $258.00 to $270.00.
B of A Securities Maintains Neutral on Danaher, Raises Price Target to $270
Leerink Partners Adjusts Danaher Price Target to $275 From $265
RBC Raises Price Target on Danaher to $297 From $284, Keeps Outperform Rating
Baird: Maintaining the Danaher (DHR.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $259.00 to $271.00.
Danaher Analyst Ratings
Baird Maintains Outperform on Danaher, Raises Price Target to $271
Goldman Sachs Raises Danaher Price Target to $220 From $215
Evercore ISI Adjusts Price Target on Danaher to $266 From $260
RBC Capital Reaffirms Their Buy Rating on Danaher (DHR)
Danaher Analyst Ratings
HSBC: Upgraded the Danaher (DHR.US) rating from holding to buying, and adjusted the target price from $250.00 to $280.00.
Leerink Partners Adjusts Danaher's Price Target to $265 From $255
Barclays: Maintaining the Danaher (DHR.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $240.00 to $260.00.
Danaher Analyst Ratings
RBC Lifts Price Target on Danaher to $284 From $282, Keeps Outperform Rating
Danaher Analyst Ratings
Deutsche Bank Adjusts Danaher Price Target to $270 From $250, Maintains Buy Rating
Analysis
Price Target
No Data
